Should I buy or sell Aurora Cannabis stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ACB shares. View ACB analyst ratings or view top-rated stocks .

How have ACB shares performed in 2024?

Aurora Cannabis' stock was trading at $4.7620 at the start of the year. Since then, ACB shares have increased by 31.9% and is now trading at $6.28. View the best growth stocks for 2024 here .

When is Aurora Cannabis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024. View our ACB earnings forecast .

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (NASDAQ:ACB) posted its quarterly earnings results on Thursday, February, 8th. The company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.10) by $0.10. The company had revenue of $53.34 million for the quarter, compared to analyst estimates of $45.94 million. Aurora Cannabis had a negative net margin of 48.82% and a negative trailing twelve-month return on equity of 23.27%.

What ETF holds Aurora Cannabis' stock?

Cambria Cannabis ETF holds 36,428 shares of ACB stock, representing 2.42% of its portfolio.

When did Aurora Cannabis' stock split?

Aurora Cannabis shares reverse split before market open on Tuesday, February 20th 2024. The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

How do I buy shares of Aurora Cannabis?

Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Aurora Cannabis have any subsidiaries?

The following companies are subsidiares of Aurora Cannabis: 1769474 Alberta Ltd., 2105657 Alberta Inc., ACB Captive Insurance Company Inc., Anandia Labs Inc, Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Aurora Nordic Cannabis A/S, CanniMed Therapeutics Inc., CanvasRx Holdings, ICC Labs Inc., Larssen Ltd, MedReleaf Corp., Pedanios, Peloton Pharmaceuticals Inc., Reliva LLC, Reliva LLC, Whistler Medical Marijuana Corporation, and Whistler Medical Marijuana Corporation. Read More

NASDAQ:ACB

Aurora Cannabis (ACB) Stock Price, News & Analysis

→ REVEALED: Elon Musk’s Secret A.I. Facility? (From InvestorPlace) (Ad)

Free ACB Stock Alerts

$6.03

-0.25 (-3.98%)

(As of 11:22 AM ET)

Compare

Today's Range: $5.64
▼
$6.17
50-Day Range: $2.89
▼
$7.21
52-Week Range: $2.84
▼
$11.50

Volume: 3.52 million shs
Average Volume: 4.61 million shs
Market Capitalization: $328.88 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Aurora Cannabis alerts:

Aurora Cannabis MarketRank™ Stock Analysis

Analyst Rating: N/A
Upside/Downside: N/A
Short Interest: Bearish
32.80% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 0.29
Based on 2 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($0.85) to ($0.32) Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.11 out of 5 stars

Medical Sector

912th out of 928 stocks

Medicinals & Botanicals Industry

11th out of 11 stocks

N/A

Analyst's Opinion

Consensus Rating
There is not enough analysis data for Aurora Cannabis.

2.0

Short Interest

Percentage of Shares Shorted
32.80% of the float of Aurora Cannabis has been sold short.
Short Interest Ratio / Days to Cover
Aurora Cannabis has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Aurora Cannabis has recently increased by 32.98%, indicating that investor sentiment is decreasing significantly.

0.0

Dividend Strength

Dividend Yield
Aurora Cannabis does not currently pay a dividend.
Dividend Growth
Aurora Cannabis does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ACB.

1.8

News and Social Media Coverage

News Sentiment
Aurora Cannabis has a news sentiment score of 0.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 2 news articles for Aurora Cannabis this week, compared to 2 articles on an average week.
Search Interest
54 people have searched for ACB on MarketBeat in the last 30 days. This is an increase of 69% compared to the previous 30 days.
MarketBeat Follows
Only 26 people have added Aurora Cannabis to their MarketBeat watchlist in the last 30 days. This is a decrease of -10% compared to the previous 30 days.

0.8

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Aurora Cannabis insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.01% of the stock of Aurora Cannabis is held by insiders.
Percentage Held by Institutions
47.63% of the stock of Aurora Cannabis is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Aurora Cannabis are expected to grow in the coming year, from ($0.85) to ($0.32) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Aurora Cannabis is -2.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Aurora Cannabis is -2.17, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

Click here to see the details because there’s a lot of money at stake.

About Aurora Cannabis Stock (NASDAQ:ACB)

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

ACB Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ACB Stock News Headlines

April 2, 2024 | marketbeat.com

Green Gold Rush: Here's What's Driving Cannabis Stocks Higher

Various themes and sectors garnered buzz and attention as the first quarter drew to a close. However, one industry that has been in a lull for a significant period reignited the imagination and hope of longstanding investors after it finished the first quarter in style.

April 2, 2024 | marketbeat.com

Green Gold Rush: Here's What's Driving Cannabis Stocks Higher (ACB)

Over the previous month, several cannabis stocks surged dramatically, igniting the sector as gains reached double- to even triple-digits in some cases.

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

April 9, 2024 | fool.com

Why Marijuana Stocks Got Burnt Today

April 8, 2024 | fool.com

Why Canopy Growth, Cronos, and Aurora Cannabis Stocks Popped on Monday

April 4, 2024 | investorplace.com

Cannabis Stocks Alert: 3 Big Reasons TLRY, ACB, CGC and SNDL Keep Gaining

April 4, 2024 | benzinga.com

Amazon, Disney, Aurora Cannabis, Paramount Global, Tesla: Why These Stocks Are On Investors' Radars Today

April 3, 2024 | msn.com

Canadian cannabis stocks rally as industry exec. elected to lead lobby group

April 16, 2024 | InvestorPlace (Ad)

REVEALED: Elon Musk’s Secret A.I. Facility?

I recently shot this video outside what could be Elon Musk’s biggest secret. What’s happening inside these walls is so important that our government has declared it a matter of national security.

April 3, 2024 | fool.com

Is Aurora Cannabis Set to Take Off After Soaring 39% in the Past Month?

April 1, 2024 | investorplace.com

Cannabis Stocks Alert: Recreational Marijuana Just Became Legal in Germany

March 26, 2024 | investorplace.com

Cannabis Stocks Heat Up Again Ahead of German Rollout

March 25, 2024 | fool.com

Why Aurora Cannabis Stock Dropped 12% Today

March 25, 2024 | investorplace.com

Cannabis Stocks CGC, ACB, TLRY, SNDL Already Fading Despite German Legalization

March 21, 2024 | marketwatch.com

Aurora Cannabis Rises After Certification in Australia

March 20, 2024 | prnewswire.com

Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance

March 18, 2024 | finance.yahoo.com

ACB Apr 2024 3.000 put

March 15, 2024 | ca.finance.yahoo.com

ACB Jan 2026 5.500 call

March 14, 2024 | wsj.com

Aurora Cannabis Inc.

March 14, 2024 | finance.yahoo.com

ACB Jan 2026 5.000 put

March 14, 2024 | finance.yahoo.com

ACB Apr 2024 5.000 call

March 13, 2024 | finance.yahoo.com

ACB Mar 2024 6.000 call

March 13, 2024 | finance.yahoo.com

ACB Mar 2024 3.000 put

March 11, 2024 | finance.yahoo.com

ACB Apr 2024 4.500 put

March 11, 2024 | finance.yahoo.com

ACB Apr 2024 2.000 call

March 4, 2024 | investorplace.com

Hidden Gems: 7 Oversold Stocks Ready for a Major Rebound

March 2, 2024 | finance.yahoo.com

ACB Mar 2024 4.000 call

See More Headlines

Receive ACB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/08/2024
Today: 4/16/2024
Next Earnings (Estimated): 6/12/2024
Fiscal Year End: 3/31/2025

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Medicinals & botanicals
Sub-Industry: N/A
Current Symbol: NASDAQ:ACB
Previous Symbol: NYSE:ACB
CUSIP: N/A
CIK: 1683541
Web: auroramj.com
Phone: (855) 279-4652
Fax: N/A
Employees: 1,130
Year Founded: 2006

Profitability

EPS (Most Recent Fiscal Year): ($2.90)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-799,220,000.00
Net Margins: -48.82%
Pretax Margin: N/A
Return on Equity: -23.27%
Return on Assets: -15.75%

Debt

Debt-to-Equity Ratio: 0.14
Current Ratio: 3.79
Quick Ratio: 2.45

Sales & Book Value

Annual Sales: $174.88 million
Price / Sales: 1.96
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: 54,540,000
Free Float: 54,534,000
Market Cap: $342.51 million
Optionable: Optionable
Beta: 2.36

Social Links

The Best High-Yield Dividend Stocks for 2024

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

Mr. Miguel Martin (Age 51)
CEO & Director
Comp: $1.47M
Mr. Alex Miller
Executive Vice President of Operations & Supply Chain
Ms. Lori Schick
Executive Vice President of Human Resources
Mr. Andre Jerome
Executive Vice President of Global Business Development
Ms. Simona King (Age 51)
Chief Financial Officer
Ananth Krishnan
Vice President of Capital Markets & Investor Relations
Ms. Nathalie Clark
Executive VP, General Counsel & Corporate Secretary
Michelle Lefler
Vice President of Communications & Public Relations
Dr. Jonathan Page Ph.D. (Age 55)
Senior Science Advisor
Mr. Rick Savone
Senior Vice President of Global Government Relations

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

ACB Stock Analysis - Frequently Asked Questions

Should I buy or sell Aurora Cannabis stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ACB shares.
View ACB analyst ratings or view top-rated stocks.
How have ACB shares performed in 2024?: Aurora Cannabis' stock was trading at $4.7620 at the start of the year. Since then, ACB shares have increased by 31.9% and is now trading at $6.28.
View the best growth stocks for 2024 here.
When is Aurora Cannabis' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024.
View our ACB earnings forecast.
How were Aurora Cannabis' earnings last quarter?: Aurora Cannabis Inc. (NASDAQ:ACB) posted its quarterly earnings results on Thursday, February, 8th. The company reported ($0.20) EPS for the quarter, missing the consensus estimate of ($0.10) by $0.10. The company had revenue of $53.34 million for the quarter, compared to analyst estimates of $45.94 million. Aurora Cannabis had a negative net margin of 48.82% and a negative trailing twelve-month return on equity of 23.27%.

What ETF holds Aurora Cannabis' stock?: Cambria Cannabis ETF holds 36,428 shares of ACB stock, representing 2.42% of its portfolio.
When did Aurora Cannabis' stock split?: Aurora Cannabis shares reverse split before market open on Tuesday, February 20th 2024. The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.
How do I buy shares of Aurora Cannabis?: Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Aurora Cannabis have any subsidiaries?: The following companies are subsidiares of Aurora Cannabis: 1769474 Alberta Ltd., 2105657 Alberta Inc., ACB Captive Insurance Company Inc., Anandia Labs Inc, Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Aurora Nordic Cannabis A/S, CanniMed Therapeutics Inc., CanvasRx Holdings, ICC Labs Inc., Larssen Ltd, MedReleaf Corp., Pedanios, Peloton Pharmaceuticals Inc., Reliva LLC, Reliva LLC, Whistler Medical Marijuana Corporation, and Whistler Medical Marijuana Corporation.
Read More

This page (NASDAQ:ACB) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Aurora Cannabis (ACB) Stock Price, News & Analysis

Aurora Cannabis MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Aurora Cannabis Stock (NASDAQ:ACB)

ACB Stock Price History

ACB Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Institutional Ownership

ACB Stock Analysis - Frequently Asked Questions

Overall MarketRank^™